VRXA Veraxa Biotech AG - Ordinary Shares
No fundamentals data yet for this ticker.
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Schoeni Gilbert Edgar | June 15, 2026 | 15.90% | Initial filing | Passive investment | SEC |
| Xlife Sciences AG | June 15, 2026 | 16.30% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.